| The use of renin-angiotensin system (RAS) inhibitors is alleged to cause a more severe course of coronavirus disease 2019 (COVID-19). |
| We systematically reviewed the published studies to assess the association of RAS inhibitors with mortality as well as disease severity in COVID-19 patients. |
| The meta-analyses favoured the continued use of RAS inhibitors in terms of risk of mortality and severe/critical COVID-19 disease. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.